Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Bendstrup

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Trials|September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
The New England Journal of Medicine|August 20, 2025
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisBruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
Biomedicines|August 26, 2022
Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial PopulationPeter Kamstrup, Jannie Marie Bülow Sand, Charlotte Suppli Ulrik, et al.
The Lancet. Rheumatology|December 24, 2024
Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort studyMichael G Matt, Daniel Drozdov, Elisabeth Bendstrup, et al.
Biomedicines|April 29, 2025
Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary DiseaseDaniel Alexander Ackermann, Allan Linneberg, Ema Rastoder, et al.
BMC Pulmonary Medicine|February 3, 2025
Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international surveyEmil Vilstrup Moen, Thomas Skovhus Prior, Michael Kreuter, et al.
Respirology (Carlton, Vic.)|September 18, 2022
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in EuropeTheodoros Karampitsakos, Paolo Spagnolo, Nesrin Mogulkoc, et al.
European Clinical Respiratory Journal|January 9, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) studyJann Mortensen, Lars Kristensen, Mathias Munkholm, et al.
Frontiers in Medicine|October 14, 2021
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the WorldMarkus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Trials|September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
The New England Journal of Medicine|August 20, 2025
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisBruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
Biomedicines|August 26, 2022
Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial PopulationPeter Kamstrup, Jannie Marie Bülow Sand, Charlotte Suppli Ulrik, et al.
The Lancet. Rheumatology|December 24, 2024
Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort studyMichael G Matt, Daniel Drozdov, Elisabeth Bendstrup, et al.
Biomedicines|April 29, 2025
Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary DiseaseDaniel Alexander Ackermann, Allan Linneberg, Ema Rastoder, et al.
BMC Pulmonary Medicine|February 3, 2025
Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international surveyEmil Vilstrup Moen, Thomas Skovhus Prior, Michael Kreuter, et al.
Respirology (Carlton, Vic.)|September 18, 2022
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in EuropeTheodoros Karampitsakos, Paolo Spagnolo, Nesrin Mogulkoc, et al.
European Clinical Respiratory Journal|January 9, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) studyJann Mortensen, Lars Kristensen, Mathias Munkholm, et al.
Frontiers in Medicine|October 14, 2021
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the WorldMarkus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, et al.
Pageof 22